Marjolein L. Smidt - Concepedia

Author

Marjolein L. Smidt

Also Known As

Hillege, Lars E., M L Smidt, M. (Marjolein) Smidt, M. L. Smidt, M. Smidt, M.L. Smidt, Marjolein L Smidt, Marjolein L. Smidt, Marjolein Louisa Smidt, Marjolein Smidt

227

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Maastricht University Maastricht University Medical Centre Radboud University Nijmegen Zuyderland Medisch Centrum Netherlands Comprehensive Cancer Organisation

About

Marjolein L. Smidt is an author at Maastricht University specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	716
2	Health Sciences	9	9	636
3	Engineering	7	7	562
4	Biostatistics	3	3	243
5	Data Science	1	1	21

Marjolein L. Smidt

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme Marc B. I. Lobbes, Ulrich Lalji, Janneke B. Houwers, European Radiology EngineeringMedical ImagingCancer DetectionCancer ScreeningBiomedical Imaging	2014	202
Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study Marissa C. van Maaren, Linda de Munck, Luc J. A. Strobbe, International Journal of Cancer	2018	167
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08) Lori M. van Roozendaal, M. Vane, Thijs van Dalen, BMC Cancer	2017	165
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment Safae Terrisse, Lisa Derosa, Valerio Iebba, Cell Death and Differentiation	2021	154
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Journal of Hematology & Oncology	2021	152
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients Jorne Ubachs, Janine Ziemons, Zita Soons, Journal of Cachexia Sarcopenia and Muscle	2021	136
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study Ulrich Lalji, Ivo Houben, Renate Prevos, European Radiology	2016	133
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients B. Goorts, Thiemo J. A. van Nijnatten, Linda de Munck, Breast Cancer Research and Treatment	2017	129
The Quality of Tumor Size Assessment by Contrast-Enhanced Spectral Mammography and the Benefit of Additional Breast MRI Marc B. I. Lobbes, Ulrich Lalji, Patty J. Nelemans, Journal of Cancer EngineeringBreast MriDiagnosisDiagnostic ImagingMagnetic Resonance Imaging	2015	123
Maastricht Delphi Consensus on Event Definitions for Classification of Recurrence in Breast Cancer Research M. Moossdorff, Lori M. van Roozendaal, Luc J. A. Strobbe, JNCI Journal of the National Cancer Institute	2014	113

Page 1